Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Combined Hepatocellular Carcinoma and Cholangiocarcinoma”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Early research (Phase 1)Study completedNCT03000257
What this trial is testing

Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
AbbVie 182
Testing effectiveness (Phase 2)Active Not RecruitingNCT04175912
What this trial is testing

Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver

Who this might be right for
Metastatic CholangiocarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8+12 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT02042443
What this trial is testing

Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

Who this might be right for
Adult CholangiocarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage C Adult Hepatocellular Carcinoma+16 more
National Cancer Institute (NCI) 53
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Testing effectiveness (Phase 2)Study completedNCT00019474
What this trial is testing

Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer

Who this might be right for
Extrahepatic Bile Duct CancerGastric CancerGastrointestinal Carcinoid Tumor+3 more
Montefiore Medical Center 60
Not applicableStudy completedNCT02730611
What this trial is testing

Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma

Who this might be right for
Morbid ObesityVertical Sleeve GastrectomyMetabolic Syndrome+3 more
Assistance Publique - Hôpitaux de Paris 124
Early research (Phase 1)Study completedNCT00019513
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Testing effectiveness (Phase 2)Looking for participantsNCT07105748
What this trial is testing

HAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA)

Who this might be right for
Mixed Hepatocellular-cholangiocarcinoma
Fudan University 45
Testing effectiveness (Phase 2)Ended earlyNCT01229111
What this trial is testing

Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers

Who this might be right for
Adult Primary Cholangiocellular CarcinomaAdvanced Adult Primary Liver CancerCholangiocarcinoma of the Extrahepatic Bile Duct+8 more
National Cancer Institute (NCI) 14
Not applicableLooking for participantsNCT06849180
What this trial is testing

Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data

Who this might be right for
Combined Hepatocellular-cholangiocarcinomaCombined Hepatocellular Carcinoma and CholangiocarcinomaCombined Hepatocellular and Cholangiocarcinoma
Zhongda Hospital 198
Not applicableUnknownNCT05662488
What this trial is testing

FAPI PET for Response Evaluation and Prognosis Prediction in Liver and Biliary Cancer Patients Treated With PD-1 Combination Therapy

Who this might be right for
Hepatocellular CarcinomaBile Duct Cancer
Peking Union Medical College Hospital 25
Not applicableActive Not RecruitingNCT05064553
What this trial is testing

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerHepatitis B+2 more
Exact Sciences Corporation 2,990
Testing effectiveness (Phase 2)Looking for participantsNCT05223816
What this trial is testing

An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma

Who this might be right for
Hepatocellular CarcinomaIntrahepatic Cholangiocarcinoma
Virogin Biotech Canada Ltd 97
Early research (Phase 1)Study completedNCT00031681
What this trial is testing

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixEstrogen Receptor-negative Breast Cancer+85 more
National Cancer Institute (NCI) 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT04941287
What this trial is testing

Testing A New Combination of Anti-cancer Immune Therapies, Atezolizumab and CDX-1127 (Varlilumab) With or Without the Addition of a Third Anti-cancer Drug, Cobimetinib, for Advanced-Stage Biliary Tract Cancer

Who this might be right for
Metastatic Distal Bile Duct AdenocarcinomaMetastatic Gallbladder CarcinomaMetastatic Intrahepatic Cholangiocarcinoma+7 more
National Cancer Institute (NCI) 57
Testing effectiveness (Phase 2)Study completedNCT03230318
What this trial is testing

Derazantinib in Subjects With FGFR2 Gene Fusion-, Mutation- or Amplification- Positive Inoperable or Advanced Intrahepatic Cholangiocarcinoma

Who this might be right for
Intrahepatic CholangiocarcinomaCombined Hepatocellular and Cholangiocarcinoma
Basilea Pharmaceutica 148
Early research (Phase 1)UnknownNCT05240690
What this trial is testing

Umbilical Cord Blood Derived MAK Immune Cells Combined With Standard Second-Line Treatments for Hepatobiliary and Pancreatic Malignancies

Who this might be right for
Stage IV Pancreatic CancerHepatocellular Carcinoma , Cholangiocarcinoma
Zhou Fuxiang 27
Early research (Phase 1)Study completedNCT03829436
What this trial is testing

TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers

Who this might be right for
Hepatocellular CarcinomaMetastatic Castration Resistant Prostate CancerRenal Cell Carcinoma+9 more
Tempest Therapeutics 38
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07243951
What this trial is testing

Phase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuvant Therapy for Combined Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Who this might be right for
Combined Hepatocellular-cholangiocarcinomaLiver Neoplasms
Shanghai Zhongshan Hospital 75
Load More Results